openPR Logo
Press release

Histone Deacetylase Inhibitors Market (COVID-19 Impact Analysis), 2020 Insights, Status, Latest Amendments And Outlook | Midatech Pharma PLC, Crystal Genomics, Novartis AG, Celleron Therapeutics, Pfizer

10-12-2020 02:54 PM CET | Health & Medicine

Press release from: Data Bridge Market Research Pvt. Ltd.

Histone Deacetylase Inhibitors Market

Histone Deacetylase Inhibitors Market

The HISTONE DEACETYLASE INHIBITORS Market report makes available a thoughtful overview of product specification, technology, product type and production analysis taking into account major factors such as revenue, cost, and gross margin. The report is sure to offer brilliant solution to the challenges and problems faced by industry. This market report comprises of extensive study about miscellaneous market segments and regions, emerging trends, major market drivers, challenges and opportunities in the market. This HISTONE DEACETYLASE INHIBITORS Market document also displays the key developments in the industry with respect to current scenario and the approaching advancements.

Get Exclusive FREE Sample Copy of This Report Here https://www.databridgemarketresearch.com/request-a-sample?dbmr=global-histone-deacetylase-inhibitors-market

This HISTONE DEACETYLASE INHIBITORS Market analysis report is a cautious investigation of current scenario of the market and future estimations which considers several market dynamics. Market research report acceptance is very essential for the business growth as it helps with the better decision making, enhancing revenue generation, prioritizing market goals & results in profitable business. It makes easy for ABC industry to visualize what is already available in the market, what market anticipates, the competitive environment & what should be done to surpass the competitor. The HISTONE DEACETYLASE INHIBITORS Market report not only aids to save valuable time but also adds credibility to the work that has been done to grow the business.

Global histone deacetylase inhibitors market is rising gradually with a healthy CAGR of 14.2% in the forecast period of 2020-2027. The report contains data of the base year 2019 and historic year 2018. Prevailing cases of neurological disorders and other chronic diseases creates avenues for this market growth

Few of the major competitors currently working in the global histone deacetylase inhibitors market are Midatech Pharma PLC, Crystal Genomics, CELGENE CORPORATION, Novartis AG, Shenzhen Chipscreen Biosciences Co., Ltd., Spectrum Pharmaceuticals, Inc., Merck & Co., Inc., Celleron Therapeutics, FORUM Pharmaceuticals Inc., Pfizer Inc., AstraZeneca, Eisai Co., Ltd., REGENACY PHARMACEUTICALS, LLC, Karyopharm Therapeutics, Aurobindo Pharma, Trovagene, Wellness Pharma International, Syndax, MEI Pharma Inc., Onxeo among others.

Read Complete Details with TOC Here https://www.databridgemarketresearch.com/toc?dbmr=global-histone-deacetylase-inhibitors-market

Market Definition: Global Histone Deacetylase Inhibitors Market

Histone deacetylase inhibitors are chemotherapy agents that inhibit histone deacetylases. These agents cause apoptosis and cell death. Histone deacetylase inhibitors are newer class of anti-cancer drugs used for treatment of T-cell lymphoma and myeloma. The drugs show good effects for hematological malignancies and epigenetic or non-epigenetic regulations.

According to World Health Organization (WHO), approximately 9.6 million deaths are reported in 2018 by cancer which includes lung, prostate, stomach and liver cancer as the most common types of cancers. The histone deacetylase inhibitor drugs show good activity for treatment of these diseases with lesser side effects.

Segmentation: Global Histone Deacetylase Inhibitors Market

Histone Deacetylase Inhibitors Market : By Classification

Class I HDACs
Class II HDACs
Class III HDACs
Others

Histone Deacetylase Inhibitors Market : By Application

Oncology
Neurology
Others

Histone Deacetylase Inhibitors Market : By Drugs

Vorinostat
Romidepsin
Belinostat
Others

Histone Deacetylase Inhibitors Market : By Route of Administration

Oral
Injectable
Others

Histone Deacetylase Inhibitors Market : By End Users

Hospitals
Homecare
Specialty Clinics
Others

Histone Deacetylase Inhibitors Market : By Distribution Channels

Hospital Pharmacy
Online Pharmacy
Retail Pharmacy
Others

Histone Deacetylase Inhibitors Market : By Geography

North America
South America
Europe
Asia-Pacific
Middle East & Africa

Key Developments in the Histone Deacetylase Inhibitors Market:

In October 2019, Midatech Pharma PLC received Orphan Drug designation from the U. S. FDA for MTX110, a non-selective histone deacetylase inhibitor used for treatment of patients with malignant glioma and diffuse intrinsic pontine glioma (DIPG). This designation will support the development of drug candidate and accelerate its approval

In August 2019, Crystal Genomics received the Orphan Drug designation from the U. S. FDA for CG-745, a histone deacetylase (HDAC) inhibitor drug candidate used for treatment of patients with pancreatic cancer. This designation will support the development of drug candidate and accelerate its approval

Key Questions Answered in Global HISTONE DEACETYLASE INHIBITORS Market Report
• What is the scope of growth of companies in the global HISTONE DEACETYLASE INHIBITORS market?
• What will be the Y-o-Y growth of the global HISTONE DEACETYLASE INHIBITORS market between 2020 and 2027?
• What is the influence of changing trends in technologies on the global HISTONE DEACETYLASE INHIBITORS market?
• Will North America continue to be the most profitable market for HISTONE DEACETYLASE INHIBITORS providers?
• Which factors will hamper the growth of the global HISTONE DEACETYLASE INHIBITORS market during the forecast period?
• Which are the leading companies in the global HISTONE DEACETYLASE INHIBITORS market?

TABLE OF CONTENTS
Part 01: Executive Summary
Part 02: Scope of the Report
Part 03: Research Methodology
Part 04: Market Landscape
• Market Ecosystem
• Market Characteristics
• Market Segmentation Analysis
Part 05: Pipeline Analysis
• Pipeline Analysis
Part 06: Market Sizing
• Market Definition
• Market Sizing
• Market Size And Forecast
Part 07: Five Forces Analysis
• Bargaining Power Of Buyers
• Bargaining Power Of Suppliers
• Threat Of New Entrants
• Threat Of Substitutes
• Threat Of Rivalry
• Market Condition
Part 08: Market Segmentation
• Segmentation
• Comparison
• Market Opportunity
Part 09: Customer Landscape
Part 10: Regional Landscape
• Geographical Segmentation
• Regional Comparison
• North America
• South America
• Europe
• MEA
• APAC
• Market Opportunity
Part 11: Decision Framework
Part 12: Drivers and Challenges
• Market Drivers
• Market Challenges
Part 13: Market Trends
Part 14: Vendor Landscape
• Overview
• Landscape Disruption
Part 15: Vendor Analysis
• Vendors Covered
• Vendor Classification
• Market Positioning Of Vendors
Part 16: Appendix
• List Of Abbreviations

To Get This Report at an Attractive Cost, Click Here https://www.databridgemarketresearch.com/inquire-before-buying?dbmr=global-histone-deacetylase-inhibitors-market

Contact Us
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Mail: Corporatesales@databridgemarketresearch.com
https://databridgemarketresearch.com

About Data Bridge Market Research:

Data Bridge Market Research is a versatile market research and consulting firm with over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Our coverage of industries include Medical Devices, Pharmaceuticals, Biotechnology, Semiconductors, Machinery, Information and Communication Technology, Automobiles and Automotive, Chemical and Material, Packaging, Food and Beverages, Cosmetics, Specialty Chemicals, Fast Moving Consumer Goods, Robotics, among many others.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude.We are content with our glorious 99.9 % client satisfying rate.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Histone Deacetylase Inhibitors Market (COVID-19 Impact Analysis), 2020 Insights, Status, Latest Amendments And Outlook | Midatech Pharma PLC, Crystal Genomics, Novartis AG, Celleron Therapeutics, Pfizer here

News-ID: 2155913 • Views:

More Releases from Data Bridge Market Research Pvt. Ltd.

The Digital Landscape: Examining the Surge in Media Monitoring Software Market Valuation to USD 7584.77 Million by 2029 with a Striking CAGR of 14.40
The Digital Landscape: Examining the Surge in Media Monitoring Software Market V …
For an excellent business growth, companies must take up market research report service which is imperative in today's market place. "Media Monitoring Software Market" research report has been produced with a nice blend of industry insight, smart and practical solutions and newest technology to endow with the better user experience. The report brings into focus several aspects related to industry and market. A few of these can be listed here
Animal Antibiotics Antimicrobials Market Sales to Top USD 6.3 billion by 2029
Animal Antibiotics Antimicrobials Market Sales to Top USD 6.3 billion by 2029
Antimicrobials are substances that kill or inhibit the majority of germs. The antimicrobials can be natural, semi-synthetic, or synthetic. Antibiotics are all antimicrobials, but antimicrobials aren't all antibiotics. Antibiotics are basically used to treat clinical illness, prevent and manage common disease occurrences, and improve animal development and growth. They are used in food animals in three ways: therapeutic, prophylactic, and sub-therapeutic. Antimicrobials offer significant advantages in terms of animal
Benzene Market Research 2021-2028: China National Petroleum Corporation, Haldia …
Market research reports help business or organization in every sphere of trade to take better decisions, to respond the toughest business questions and reduce the risk of failure. In the world class Benzene market report, data collection modules with large sample sizes are used to collect data and perform base year analysis. The market research data included in this report is analysed and forecasted using market statistical and coherent models.
Digital Inks Market Report 2021-2027: Cabot Corporation, INX International Ink C …
Digital Inks Market research reports are very influential in many ways to grow the business. Digital Inks market report is a superior and comprehensive market research report which endows professionals with a lot of aspects about the market and the industry. The marketing report presents market potential for each geographical region based on the growth rate, macroeconomic parameters, consumer buying patterns, their preferences for particular product and market demand and

All 5 Releases


More Releases for Histone

Global Histone Deacetylase Inhibitors Market Research Report
This report studies the global Histone Deacetylase Inhibitors market status and forecast, categorizes the global Histone Deacetylase Inhibitors market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report 4SC AG Acetylon Pharmaceuticals Celleron Therapeutics Chroma Therapeutics CrystalGenomics Curis MEI Pharma Mirati Therapeutics Novartis
Histone Methyltransferases Market Growth Analysis 2019
Histones are the major protein constituents of eukaryotic nucleus. Histone methyltransferases catalyzes the transfer of methyl group to lysine and arginine residues of the histone protein. It catalyzes the reaction with the help of SN-2 mechanism where transfer of methyl group from S Adenosyl Methionine to amino group of target lysine takes place. There are seven histone methyltransferase includes EZ, SET1, SET2, SMYD, SUV39, SUV4-20 and RIZ. The main function
Histone Deacetylase (HDAC) Inhibitors - Pipeline Insights 2017
The “Histone Deacetylase (HDAC) Inhibitors - Pipeline Insights 2017″ report provides a comprehensive analysis of HDAC drug candidates currently undergoing clinical trials. It covers detailed drug profiles of potential HDAC inhibitors across various clinical development phases including–discovery, pre-clinical, IND, Phase I, Phase II, Phase III and pre-registration. The report also includes the pipeline products’ clinical trial data along with information on other development activities, including technology, licensing, collaborations, acquisitions, funding,
Histone Deacetylase (HDAC) Inhibitors - Pipeline Insights 2017
The “Histone Deacetylase (HDAC) Inhibitors - Pipeline Insights 2017″ report provides a comprehensive analysis of HDAC drug candidates currently undergoing clinical trials. It covers detailed drug profiles of potential HDAC inhibitors across various clinical development phases including–discovery, pre-clinical, IND, Phase I, Phase II, Phase III and pre-registration. The report also includes the pipeline products’ clinical trial data along with information on other development activities, including technology, licensing, collaborations, acquisitions, funding,
Histone Deacetylase Inhibitors Market & Pipeline Insight2015
Histone Deacetylase (HDAC) are enzymes responsible for removal of acetyl groups present on acetyl lysine amino acid attached to histone. They are responsible for gene expression and regulation which is responsible for cellular functioning. It also helps in wrapping of histone over the Deoxyribonucleic acid (DNA). They are involved in cell growth and death which is responsible for maintaining steady state. Their involvement in diseases has been noted by investigators
Histone Deacetylase 4 (Histone Deacetylase A or HDAC4 or EC 3.5.1.98) - Pipeline …
The latest report Histone Deacetylase 4 - Pipeline Review, H1 2017, outlays comprehensive information on the Histone Deacetylase 4 (Histone Deacetylase A or HDAC4 or EC 3.5.1.98) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviewsalso reviews key players involved in Histone Deacetylase 4 (Histone Deacetylase A or HDAC4 or EC 3.5.1.98) targeted therapeutics development